Dr. Goldis discusses FDA’s approval of new controversial drug that treats Alzheimer’s disease

Sunrise Interviews

BAKERSFIELD, Calif. (KGET) – Dr. Glenn Goldis, Chief Medical Officer for Kern Medical, joined 17 News at Sunrise to discuss the FDA’s recent approval of a new controversial drug that treats Alzheimer’s disease.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.